Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2021
Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of HepatotoxicityMatthew M Cousins, Theresa P Devasia, Christopher M Maurino, et al.The Pediatric Infectious Disease Journal|July 13, 2012
Use of a high resolution melting assay to analyze HIV diversity in HIV-infected Ugandan childrenMaria M James, Lei Wang, Deborah Donnell, et al.Translational Oncology|January 5, 2021
TNFR1 and the TNFα axis as a targetable mediator of liver injury from stereotactic body radiation therapyMatthew M Cousins, Emily Morris, Christopher Maurino, et al.Journal of Clinical Microbiology|July 13, 2012
Comparison of a high-resolution melting assay to next-generation sequencing for analysis of HIV diversityMatthew M Cousins, San-San Ou, Maria J Wawer, et al.Practical Radiation Oncology|June 9, 2023
Efficacy of a Second Course of Radiation for Patients With Metachronous Hepatocellular CarcinomaLaila A Gharzai, Chang Wang, Ming Tang, et al.Plos One|March 6, 2013
Antibody maturation and viral diversification in HIV-infected womenMaria M James, Oliver Laeyendecker, Jin Sun, et al.Plos One|November 11, 2011
Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infectionMatthew M Cousins, Oliver Laeyendecker, Geetha Beauchamp, et al.The Journal of Infectious Diseases|November 7, 2012
HIV incidence determination in the United States: a multiassay approachOliver Laeyendecker, Ron Brookmeyer, Matthew M Cousins, et al.Journal of Clinical Microbiology|October 25, 2013
HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithmMatthew M Cousins, Jacob Konikoff, Oliver Laeyendecker, et al.Plos One|January 4, 2014
Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United StatesJacob Konikoff, Ron Brookmeyer, Andrew F Longosz, et al.Pageof 3